JPRN-jRCTs051190090进行中（未招募）3 期
Randomized phase III controlled trial of Primary Debulking Surgery (PDS) and Neoadjuvant Chemotherapy + Interval Debulking Surgery (NAC / IDS) in patients with stage IIIC / IV ovarian cancer - SUNNY trial
Kato Kazuyoshi0 个研究点目标入组 488 人开始时间: 2019年12月25日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 488
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •The subjects of this study are patients who meet the following requirements.
- •1. Women over 18
- •2. Pathologically confirmed stage IIIC or IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer
- •3. ECOG performance status 0- 2
- •4. ASA score 1-2
- •5. Patients who have the bone marrow function, liver function and kidney function that are applicable to chemotherapy and surgery
- •6. Patients who can comply with the study plan and follow-up
- •7. Patients for whom written consent was obtained
排除标准
- •Patients who fall under any of the following are excluded from this study:
- •1. Patients with non-epithelial tumor or borderline malignant tumor
- •2. patients with low-grade carcinoma
- •3. Patients with ovarian mucinous carcinoma
- •4. Patients with synchronous or metachronous (within 5 years) malignancy other than breast cancer with carcinoma in situ or no signs of recurrence or activity
- •5. Patients who have contraindications for surgery or chemotherapy that may impair compliance with the protocol
- •6. Patients who have informed consent, study procedures, religions that may inhibit follow-up, mental factors etc.
研究者
相似试验
进行中（未招募）
1 期
Randomized phase III study of a treatment driven by early PET response compared to a treatment not monitored by early PET in patients with Ann Arbor Stage III-IV or high risk IIB Hodgkin lymphoma - AHL2011EUCTR2010-022844-19-FRCHU de Dijon810
进行中（未招募）
1 期
Randomized phase III study of a treatment driven by early PET response compared to a treatment not monitored by early PET in patients with Ann Arbor Stage III-IV or high risk IIB Hodgkin lymphoma - AHL2011Hodgkin Lymphoma not previously treatedMedDRA version: 14.1Level: LLTClassification code 10020328Term: Hodgkin's lymphomaSystem Organ Class: 100000004864EUCTR2010-022844-19-BECHU de Dijon810
进行中（未招募）
不适用
A Phase III randomized trial investigating the duration of adjuvant therapy with the modified FOLFOX 6 regimen (3 versus 6 months) for patients with stage III colon cancer. - IDEAEUCTR2009-010384-16-FRGERCOR
招募中
3 期
Comparsion of D2 verus D3 surgical procedure outcome in locally advanced gastric cancer patients following perioperative chemotherapyCTRI/2013/08/003882Tata Memorial Hospital287
已完成
3 期
ISG/AIEOP EW-1: Randomised controlled trial for patients with non-metastatic Ewing sarcomaCancerISRCTN50580483Italian Sarcoma Group (Italy)220